Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

PTCT — PTC Therapeutics, Inc. Dilution Risk Tracker

Track PTCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTCT — Get alerts when the score changes →

As of August 28, 2026, PTC Therapeutics, Inc. (PTCT) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. PTC Therapeutics, Inc. has a market capitalization of $6.13B, 83.46M shares outstanding, 354 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway
📊Float Risk
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 56% potential dilution
• Convertible risk score very high (85/100)
🔔 Track PTCT — Get forecast alerts →

Market Data

Market Cap$6.13B
Shares Outstanding83.46M
FloatN/A
Cash$2.23B
Debt$590.97M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.0% shares (2026Q1 vs prior)
354 institutional holders · 113.80M shares
#1 JANUS HENDERSON GROUP PLC 14.39M shares
#2 BlackRock, Inc. 12.95M shares
#3 RTW INVESTMENTS, LP 7.75M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.57M
Days to Cover7.5
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-09-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PTCT Dilution Snapshot

PTC Therapeutics, Inc. (PTCT) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PTCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for PTCT
PTCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.